SCHEMBL131940

SCHEMBL131940

C=CCOS(=O)(=O)O.C=CCOS(=O)(=O)O.[NaH]

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.34
CA9 Q16790 2/20 0.34
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA7 P43166 1/20 0.31
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537487 1.00 CA2 (0.34) CA2CA9CA12CA1CA7
SCHEMBL2541678 1.00
Sulfuric Acid SCHEMBL29020621 0.97 CA2 (0.33) CA2CA9CA12CA1CA7
SCHEMBL29655 0.97
SCHEMBL28900865 0.97 CA2 (0.36) CA2CA9CA12CA1CA7
SCHEMBL15349414 0.97 CA2 (0.36) CA2CA9CA12CA1CA7
SCHEMBL2537776 0.95
Hydrochloric Acid SCHEMBL15918860 0.95
Rubidium SCHEMBL2548472 0.95
SCHEMBL2548470 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1975226-B2 Liquid treatment composition PROCTER & GAMBLE (US) 2019-03-13 EP disclosed
US-8969281-B2 Liquid treatment composition THE PROCTER & GAMBLE COMPANY (US) 2015-03-03 US disclosed
EP-1975226-B1 Liquid treatment composition PROCTER & GAMBLE (US) 2013-02-13 EP disclosed
US-8357648-B2 Liquid treatment unitized dose composition THE PROCTER & GAMBLE COMPANY (US) 2013-01-22 US disclosed
US-8236745-B2 Liquid treatment composition THE PROCTER & GAMBLE COMPANY (US) 2012-08-07 US disclosed
US-8188026-B2 Liquid treatment composition THE PROCTER & GAMBLE COMPANY (US) 2012-05-29 US disclosed
EP-2426192-A1 Liquid treatment composition The Procter & Gamble Company (US) 2012-03-07 EP disclosed
US-8003589-B2 Laundry composition THE PROCTER & GAMBLE COMPANY (US) 2011-08-23 US disclosed
US-7910535-B2 Liquid treatment composition comprising a pearlescent agent THE PROCTER & GAMBLE COMPANY (US) 2011-03-22 US disclosed
US-20110034366-A1 LIQUID TREATMENT COMPOSITION PANANDIKER RAJAN KESHAV 2011-02-10 US disclosed
EP-1975225-A1 Detergent composition The Procter and Gamble Company (US) 2008-10-01 EP disclosed
US-20080234169-A1 Detergent composition PROCTER & GAMBLE COMPANY, THE 2008-09-25 US disclosed
US-20080229519-A1 Liquid treatment composition PROCTER & GAMBLE COMPANY, THE 2008-09-25 US disclosed
WO-2008114226-A1 LIQUID TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2008-09-25 WO disclosed
WO-2008114225-A1 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2008-09-25 WO disclosed
WO-2007111887-A2 LAUNDRY COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
WO-2007111898-A2 LIQUID TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
WO-2007111888-A1 LIQUID TREATMENT UNITIZED DOSE COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
WO-2007111899-A2 LIQUID TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed
WO-2007111892-A2 LIQUID TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-10-04 WO disclosed